← Back to headlines
AC Immune Stock Rises After Amending Licensing Deal with Lilly
AC Immune's stock experienced a rise after the company announced an amendment to its licensing deal with pharmaceutical giant Eli Lilly.
7 Apr, 14:45 — 7 Apr, 14:45
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Metro Cebu Water District and Manila Water Expand Water Access in Compostela
15m ago
Man accused of scamming investors in failed bid to buy Playboy's Honey Birdette
25m ago
Portugal's Recovery and Resilience Plan approves 478 new applications
25m ago